Posted by Michael Wonder on 03 Jul 2024
Novavax submits application to Health Canada for updated protein-based 2024-2025 formula COVID-19 vaccine
2 July 2024 - Novavax's filing is aligned with NACI, US. FDA, EMA and WHO recommendations on vaccine composition.
Novavax announced that it has filed for authorisation with Health Canada for its 2024-2025 formula COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.
